Salesforce (CRM)
(Delayed Data from NYSE)
$249.78 USD
-6.28 (-2.45%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $255.02 +5.24 (2.10%) 9:24 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$249.78 USD
-6.28 (-2.45%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $255.02 +5.24 (2.10%) 9:24 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Zacks News
Here's Why Salesforce.com (CRM) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Salesforce.com (CRM) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $256.06, moving +0.78% from the previous trading session.
Wall Street Analysts See Salesforce.com (CRM) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DocuSign (DOCU) Dips 12% in 6 Months: Is the Stock Worth Buying?
by Shuvra Shankar Dey
Given the recent decline in DocuSign (DOCU) shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity at this time.
Salesforce.com (CRM) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $251.22, marking a -1.88% move from the previous day.
Dropbox (DBX) Up 8.4% in a Month: How Should You Play the Stock?
by Aniruddha Ganguly
Dropbox's (DBX) strong prospects, driven by an expanding AI-powered portfolio, as well as a solid partner base, make it a long-term pick.
Company News for Jul 15, 2024
by Zacks Equity Research
Companies in The News Are: BK,T,CRM,TXN
Infosys (INFY) Expands in US Public Sector With New Contract
by Zacks Equity Research
Infosys' (INFY) Infosys Public Services receives a contract from the Delaware Department of Labor to modernize the latter's unemployment insurance system and paid family medical leave program.
Salesforce.com (CRM) Stock Moves -0.58%: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $251.12 in the latest trading session, marking a -0.58% move from the prior day.
Autodesk (ADSK) Up 10.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Autodesk (ADSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Insiders are Scooping Up Shares of These 3 Companies
by Derek Lewis
All three of these companies have recently seen insider activity, with the CEO of one making a big splash.
IBM Enhances AI Scalability With Twin Buyouts: Should You Buy?
by Supriyo Bose
With declining earnings estimates, IBM is witnessing a negative investor perception and might not be a prudent investment at the moment.
Amazon (AMZN) Up 30.1% YTD on Retail Strength: Should You Buy?
by Shilpa Mete
Amazon (AMZN) rides on retail momentum driven by e-commerce strength. This makes the stock worth a buy.
NICE's Prospects Benefit From Strong Portfolio Growth
by Zacks Equity Research
NICE business, NICE Actimize, recognized as a Leader in IDC's 2024 Enterprise Fraud Solutions assessment, leveraging AI for advanced fraud management capabilities.
Why Is Salesforce.com (CRM) Up 16% Since Last Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Here's How Much a $1000 Investment in Salesforce.com Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Oracle's (ORCL) Healthcare Expansion to Aid Long-Term Growth
by Zacks Equity Research
Oracle's (ORCL) portfolio of healthcare offerings expands with the latest Oracle Health Insurance Data Exchange Cloud Service, which is expected to aid long-term growth.
Microsoft (MSFT) Faces Charges by EU for Bundling Teams, Office
by Zacks Equity Research
Microsoft (MSFT) violates European Union antitrust laws by bundling Teams with its other popular applications for businesses, per the EU, marking the bloc's latest challenge to a U.S. tech giant.
Oracle (ORCL) Launches AI Assistant for Healthcare Providers
by Zacks Equity Research
Oracle (ORCL) announces the general availability of its Clinical Digital Assistant, an AI-powered tool designed to improve patient care in ambulatory clinics across the United States.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
The Zacks Analyst Blog Highlights Salesforce, Accenture, Equinix and Seneca Foods
by Zacks Equity Research
Salesforce, Accenture, Equinix and Seneca Foods are included in this Analyst Blog.
Top Research Reports for Salesforce, Accenture & Equinix
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Accenture plc (ACN) and Equinix, Inc. (EQIX), as well as a micro-cap stock Seneca Foods Corporation (SENEA).
NVIDIA ETFs Seesaw Last Week: What's in Store?
by Sanghamitra Saha
Chip behemoth NVIDIA (NVDA) just witnessed a volatile week, initially reaching all-time highs and then meeting with a reversal.